Antiviral drugs see demand surge in India, but segment declines 5.5%

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April

pharma, medicines, drugs
Premium

Meanwhile, the overall domestic pharma market, too, declined 11.2 per cent YoY in April after growing by almost 9 per cent in March.

Sohini Das Mumbai
With the pandemic raging across the world, the demand for antiviral drugs — especially those used for treating influenza or HIV — have shot up  as they are being tested as potential cures for Covid-19.

Data from market research firm AIOCD-AWACS shows that sales of oseltamivir (common brand Tamiflu), used against the influenza virus and also for swine flu, went up by 35.8 per cent in April on a year-on-year (YoY) basis.

Similarly, drugs like tenofovir and its combinations (anti-HIV drugs) have seen significant traction. Domestic sales of the much touted combination of lopinavir and ritonavir grew over 50 per cent in April.

First Published: May 14 2020 | 9:59 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com